Bright White Light Therapy During Cocaine Detoxification
Official title: Bright Light Therapy During Inpatient Cocaine Detoxification
Run by Hôpital le Vinatier · NCT07545798 · Data updated 2026-11-12
This study tests whether adding bright light therapy to inpatient cocaine detoxification helps people see if they feel better and maintain detoxification.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 256 (estimated) |
| Sponsor | Hôpital le Vinatier Academic / other |
| Locations | 1 site (Bron, Auvergne-Rhône-Alpes) |
| Status | Recruiting |
| Started | September 12, 2025 |
| Main results expected | September 30, 2029 |
| Study ends | December 30, 2029 |
| Registry record updated | June 12, 2026 |
| Trial ID | NCT07545798 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years and older with DSM-5 cocaine use disorder undergoing planned inpatient supervised detoxification and with health insurance coverage.
✕Probably not a fit
Individuals with non-stabilized psychiatric or somatic conditions or those using certain contraindicated medications or with retinopathy or other vision issues may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
CokeLux is a multicenter, randomized, sham-controlled, double-blind trial evaluating the use of a medical light therapy device during hospital-based cocaine detoxification. After a 10 to 17 day inpatient detox, participants will discontinue the intervention but continue follow-up data collection for one month. The study compares active light therapy to a sham device, with outcomes assessed in the hospital and after discharge. The trial design includes pre-hospitalization assessment and longitudinal data collection to monitor safety, withdrawal symptoms, and abstinence-related metrics. It targets adults with cocaine use disorder undergoing supervised detoxification and follows standard clinical research governance for medical devices.
Why it matters
Potential benefit: If successful, bright light therapy could support withdrawal management and improve recovery trajectories for patients undergoing cocaine detoxification.
How similar studies have gone: Previous studies using non-pharmacologic light therapy have shown potential benefits in mood and circadian regulation in related settings, but this specific inpatient cocaine detox context is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, 18 years of age or older * DSM-5 criteria for cocaine use disorder * Positive urine screen for cocaine * Hospitalization for supervised cocaine detoxification planned within the four upcoming weeks * The patients must be insured or beneficiary of a health insurance plan * Signed and dated informed consent document(s) indicating that the subject has been informed of all pertinent aspects of the trial Exclusion Criteria: * Non-stabilized opioid use disorder or other psychostimulant use disorder (e.g., amphetamine, met-amphetamine, cathinones, methylphenidate…) * Non-stabilized psychiatric disorder or somatic disease, which is considered incompatible with inclusion by the investigator * Current treatment with methylphenidate, modafinil, solriamfetol, melatonin pitolisant, naltrexone, or bupropion. * Contraindication to light therapy: retinopathy, pigmentary retinitis, diabetic retinopathy, macular degeneration, glaucoma, recent (i.e., less than three month) eye surgery. (If there is any doubt about an ophthalmological contraindication, a specialist opinion will be requested) * Tutorship * Pregnant or breastfeeding women: the performance of a pregnancy test before inclusion for women of childbearing age * Persons deprived of their liberty by a judicial or administrative decision * Persons participating in other research with an exclusion period still in progress at pre-inclusion
Where it's running
-
Centre Hospitalier Le Vinatier
Bron, Auvergne-Rhône-Alpes, France Recruiting
Study contacts
- Principal investigator: BENJAMIN ROLLAND, MD, PhD — Centre Hospitalier le Vinatier
- Study coordinator: FLORELLE BERTRAND, PhD
- Email: florelle.bertrand@ch-le-vinatier.fr
- Phone: 0033437915540
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if EDEN College can improve quality of life for people who hear voices
This trial tests whether EDEN College courses improve quality of life for adults who hear voices compared with usual group mental health interventions.
-
Emotional processing in adults with intellectual developmental disorder
This project will test whether adults with intellectual developmental disorder have trouble recognizing emotions and whether those difficulties are linked to attention and eye-movement processes compared with adults without IDD.
-
Combined peer support, personalized Hope Box, and postcard follow-up for suicidal inpatients
This project will try a combined program of a peer helper meeting, a personalized Hope Box, and a reminder postcard to help people hospitalized after a recent suicide attempt.
-
How cocaine use and stopping affects sleep and daily rhythms
This study tries to see how cocaine use and stopping change sleep and circadian rhythms in adults entering supervised inpatient detoxification.
-
Psychoeducation Program for Family Caregivers Coordinated by an APRN
A program led by an advanced practice nurse tests whether structured family psychoeducation can reduce the burden on caregivers of people with a first episode of psychosis.
-
See how common neurodevelopmental disorders are among people who are homeless
We’re testing how common autism, ADHD, and intellectual disability are among adults who are homeless in France.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.